In a significant move demonstrating enduring confidence in the venture capital ecosystem, Norwest Venture Partners (NVP), a prestigious firm with a 65-year legacy and backing exclusively from Wells Fargo, announced it has successfully raised a colossal $3 billion for its 17th fund. This fundraising milestone is particularly notable as it matches the firm’s previous capital raise in December 2021 — a period that represented the zenith of the venture capital boom. During that time, NVP augmented its capital pool by 50% from its $2 billion 2019 fund, a strategic move to remain competitive amidst escalating round sizes and skyrocketing valuations.
The landscape for venture capital investment, however, has witnessed significant shifts since then. The current climate is marked by a more cautious investment approach, with fewer companies receiving backing and a noticeable depression in valuations — a trend that may continue to deepen. Despite these challenges, Jeff Crowe, a senior managing partner at NVP, maintains an optimistic outlook. Acknowledging a slowdown in the general pace of venture investment and particular sectors, Crowe highlights areas such as growth equity, healthcare, and geographical markets like India, where deal-making remains as vibrant as it was prior to the economic downturn.
Crowe’s confidence is rooted in the firm’s consistent performance and strategic exits, with NVP facilitating liquidity for 36 companies since closing its preceding fund. Not all exits have yielded favourable results — for instance, the bankruptcy protection filing by portfolio company VanMoof. Yet, significant gains from successful exits, such as the sale of Spiff to Salesforce, the acquisition of Avetta by EQT for a reported $3 billion, and the IPO of Five Star Business Finance in India, have substantially outweighed the losses. The specifics of the returns remain undisclosed, but Crowe’s remarks underscore a history of delivering impressive outcomes, a vital factor contributing to the firm’s longevity and continued relevance in the venture capital sector.
A key element of NVP’s sustained success is attributed to its operation through a singular large, global, multi-strategy fund. This unique approach has enabled the firm to diversify its investment portfolio across North America, India, and Israel, embracing sectors as varied as early-stage and growth equity businesses, and even extending into biotech to complement its established healthcare practice. This diversification has afforded NVP considerable adaptability, allowing it to recalibrate its investment strategies in response to shifting market dynamics. For instance, although initially geared to leverage opportunities within the cryptocurrency sector with its last fund, the firm retracted from the space following the sector’s downturn.
This agility, as Crowe asserts, constitutes the foundational virtue of NVP’s diversified strategy, equipping the firm with the flexibility to navigate through the fluctuating landscapes of investment cycles. In essence, NVP’s latest $3 billion fund not only reflects its enduring legacy and the trust of its sole backer, Wells Fargo, but also underscores a strategic roadmap designed to adapt, thrive, and leverage opportunities through the unpredictable terrains of venture capital investment.
Source
